Quantum Biopharma (QNTM) Current Assets (2018 - 2026)

Quantum Biopharma's Current Assets history runs 9 years deep, the most recent figure standing at $10.4 million for Q1 2026.

• In Q1 2026, Current Assets rose 4.4% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $10.4 million (up 4.4% YoY), while the FY2025 annual figure was $6.5 million, down 46.25% from the prior year.
• Current Assets came in at $10.4 million for Q1 2026 at Quantum Biopharma, up from $6.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $17.9 million in Q4 2022 to a low of $6.5 million in Q4 2025.
• A 5-year average of $11.1 million and a median of $10.4 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slumped 61.14% in 2022 and rose 8.73% in 2024, its largest moves.
• Quantum Biopharma's Current Assets stood at $17.9 million in 2022, then tumbled by 37.9% to $11.1 million in 2023, then advanced by 8.73% to $12.1 million in 2024, then slumped by 46.25% to $6.5 million in 2025, then jumped by 60.06% to $10.4 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $10.4 million, $6.5 million, and $9.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison